VALLON PHARMACEUTICALS INC (VLON)
US92023M1018 - Common Stock
| 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -7.02M | -9.30M | -4.82M | -3.46M | -4.31M | |||
| Depreciation Amortization | 206.00K | 85.00K | 80.00K | 20.00K | 0.00 | |||
| Change In Working Capital | -566.00K | 220.00K | 890.00K | 160.00K | 460.00K | |||
| Interest Paid | 21.00K | 29.00K | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 249.00K | 686.00K | 150.00K | 410.00K | 1.48M | |||
| OPERATING CASH FLOW | -7.13M | -8.31M | -3.71M | -2.88M | -2.37M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Investing Activity | 3.78M | -3.84M | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | 3.78M | -3.84M | 0.00 | 0.00 | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -15.00K | 244.00K | 0.00 | 1.12M | 0.00 | |||
| Stock Issued/Repurchased | 3.45M | 15.50M | 0.00 | 4.98M | 2.99M | |||
| Other Financing Activity | N/A | N/A | 0.00 | -10.00K | 0.00 | |||
| FINANCING CASH FLOW | 3.43M | 15.75M | 0.00 | 6.09M | 2.99M | |||
| CHANGE IN CASH | 79.00K | 3.59M | -3.71M | 3.21M | 620.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -7.13M | -8.31M | -3.71M | -2.88M | -2.37M | |||
| Capital Expenditure | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| FREE CASH FLOW | -7.13M | -8.31M | -3.71M | -2.88M | -2.37M | |||
All data in USD